By expenditures
| Name | Title | Type |
|---|---|---|
| Christopher Muhvich | Director Of Finance & Operations | Auditee |
| Jackie Paradis | BUSINESS MANAGER | Auditee |
| Lisa Rider | Director of Finance and Operations | Auditee |
| Craig W. Popenhagen | Principal | Auditee |
| Thomas Olinger | Governmental Services Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 395196 | 2025 | 2026-03-27 | CLIFTONLARSONALLEN LLP | $2.07M |
| 337732 | 2024 | 2025-01-14 | Cliftonlarsonallen LLP | $2.40M |
| 11409 | 2023 | 2024-01-12 | Abdo LLP | $2.84M |
| 43243 | 2022 | 2022-12-21 | Abdo LLP | $4.79M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 395196 | 2025 | 2026-03-27 | 1190899 | 2025-002 | Material Weakness | Yes | I |
| 395196 | 2025 | 2026-03-27 | 1190898 | 2025-002 | Material Weakness | Yes | I |
| 395196 | 2025 | 2026-03-27 | 1190897 | 2025-002 | Material Weakness | Yes | I |
| 395196 | 2025 | 2026-03-27 | 1190896 | 2025-002 | Material Weakness | Yes | I |
| 395196 | 2025 | 2026-03-27 | 1190895 | 2025-002 | Material Weakness | Yes | I |
| 395196 | 2025 | 2026-03-27 | 1190894 | 2025-002 | Material Weakness | Yes | I |
| 337732 | 2024 | 2025-01-14 | 1095616 | 2024-001 | Significant Deficiency | - | I |
| 337732 | 2024 | 2025-01-14 | 1095615 | 2024-001 | Significant Deficiency | - | I |
| 337732 | 2024 | 2025-01-14 | 1095614 | 2024-001 | Significant Deficiency | - | I |
| 337732 | 2024 | 2025-01-14 | 1095613 | 2024-001 | Significant Deficiency | - | I |
| 337732 | 2024 | 2025-01-14 | 1095612 | 2024-001 | Significant Deficiency | - | I |
| 337732 | 2024 | 2025-01-14 | 519174 | 2024-001 | Significant Deficiency | - | I |
| 337732 | 2024 | 2025-01-14 | 519173 | 2024-001 | Significant Deficiency | - | I |
| 337732 | 2024 | 2025-01-14 | 519172 | 2024-001 | Significant Deficiency | - | I |
| 337732 | 2024 | 2025-01-14 | 519171 | 2024-001 | Significant Deficiency | - | I |
| 337732 | 2024 | 2025-01-14 | 519170 | 2024-001 | Significant Deficiency | - | I |
| 11409 | 2023 | 2024-01-12 | 584937 | 2023-001 | Significant Deficiency | - | P |
| 11409 | 2023 | 2024-01-12 | 584936 | 2023-001 | Significant Deficiency | - | P |
| 11409 | 2023 | 2024-01-12 | 584935 | 2023-001 | Significant Deficiency | - | P |
| 11409 | 2023 | 2024-01-12 | 584934 | 2023-001 | Significant Deficiency | - | P |
| 11409 | 2023 | 2024-01-12 | 584933 | 2023-001 | Significant Deficiency | - | P |
| 11409 | 2023 | 2024-01-12 | 8495 | 2023-001 | Significant Deficiency | - | P |
| 11409 | 2023 | 2024-01-12 | 8494 | 2023-001 | Significant Deficiency | - | P |
| 11409 | 2023 | 2024-01-12 | 8493 | 2023-001 | Significant Deficiency | - | P |
| 11409 | 2023 | 2024-01-12 | 8492 | 2023-001 | Significant Deficiency | - | P |
| 11409 | 2023 | 2024-01-12 | 8491 | 2023-001 | Significant Deficiency | - | P |